Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPsychiatry/Behavioral HealthFidelis Care Prior Auth Coverage Update | OpenPaye…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ModifiedFidelis CarePolicy N/A

    Prior Authorization and Coverage Criteria — Inpatient, Outpatient and Behavioral Health Services

    Customize your policy alerts

    Sign up for all Fidelis Care policy alerts

    Know when Fidelis Care releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs Fidelis Care authorization requirements for inpatient admissions, selected outpatient surgeries, and behavioral health services (including carve-ins and specific services requiring authorization) for providers and facilities in New York State network.

    Policy Summary
    PayerFidelis Care
    PolicyPrior Authorization and Coverage Criteria — Inpatient, Outpatient and Behavioral Health Services
    Policy CodePolicy N/A
    Change TypeBehavioral health carve‑in added
    Effective DateN/A
    Next Review DateN/A
    Key ActionObtain prior authorization for all inpatient facility admissions and for listed outpatient surgical, procedural and selected behavioral health services; notify Fidelis Care within two business days for OMH/OASAS in-state inpatient admissions to qualify for initial no-authorization periods.
    SourceLink
    POLICY UPDATE CHANGES

    Additional Behavioral Health Services are carved into the MAP Plan benefit package effective 1/1/2023 for New York State.

    All inpatientrequire authorization
    14 daysOMH pediatric waiver
    28 daysOASAS SUD waiver
    1/1/2023
    Behavioral Health carve‑in date
    8 visits/yrMNT without PA
    10 hrs/20 unitsDSMT limit

    Coverage and Authorization Criteria

    Inpatient authorization and exception criteria

    Covered when admission and notification criteria are met for OMH/OASAS in-state facilities:

    OMH <18 inpatient exception: Inpatient mental health treatment for members under age 18 provided by OMH licensed hospitals in New York State that participate in Fidelis Care's network are not subject to prior authorization review and are not subject to concurrent utilization review during the first 14 days if ALL: the facility notifies Fidelis Care of the admission and the initial treatment plan within two business days using the OMH Two-Day Notification and Initial Treatment Plan form; the facility performs daily clinical review of the patient; the facility participates in periodic consultation with Fidelis Care to ensure use of evidence-based clinical review criteria approved by OMH.first 14 days

    Services may be reviewed retrospectively.

    OASAS in-state inpatient SUD exception: Inpatient detoxification, inpatient rehabilitation and inpatient residential treatment services provided by OASAS-licensed New York facilities participating in Fidelis Care's network are not subject to prior authorization review and are not subject to concurrent utilization review during the first 28 days provided ALL: the facility notifies Fidelis Care of the inpatient admission and the initial treatment plan within two business days using the OASAS Appendix A Notification Form and the LOCADTR Medical Necessity Tool (fax/email to designated Fidelis numbers); the facility performs daily clinical review; the facility consults with Fidelis Care starting on or just prior to day 14 to ensure LOCADTR use.first 28 days

    Services may be subject to utilization review after day 28 or retrospectively.

    General inpatient/facility admissions: All inpatient facility services (medical, substance abuse, behavioral health) require prior authorization; all facility admissions are reviewed for medical necessity. Emergency room stabilization services do not require prior authorization, but post-stabilization inpatient admissions do.N/A

    Prior authorization required at time of admission except as noted for OMH/OASAS exceptions.

    Behavioral health outpatient exceptions

    Outpatient behavioral health coverage and authorization stance:

    Outpatient BH general rule: Authorization requirement has been removed from all outpatient behavioral health services except a specified list of services which continue to require authorization (psychological/neuropsychological testing, developmental pediatric testing, outpatient ECT, partial hospitalization, intensive outpatient treatment, TMS).N/A

    Out-of-state or out-of-network providers may still require authorization.

    Psychological and developmental testing: Psychological/neuropsychological testing (96116, 96121, 96130-96133, 96136-96139, 96146) and developmental pediatric testing (96112, 96113) require authorization. Note: 96110 is a non-covered service.N/A

    Use designated testing request forms for authorization submission.

    Outpatient ECT: Outpatient electroconvulsive therapy (ECT) is a listed service that requires authorization (CPT 90870).

    Behavioral Health Carve‑In Coverage

    Coverage changes for OMH/OASAS behavioral health services effective Jan 1, 2023 in MAP Plan:

    Behavioral health carve‑in: OMH/OASAS behavioral health service categories (Psychiatric Inpatient, Mental Health Outpatient Treatment and Rehabilitative Services, Assertive Community Treatment (ACT), Continuing Day Treatment (CDT), Comprehensive Psychiatric Emergency Program (CPEP), Partial Hospitalization (PH), PROS, Crisis Residence, etc.) are mapped in a crosswalk that indicates MAP Medicaid coverage beginning January 1, 2023 for hospital and freestanding settings as specified.

    See the policy crosswalk for per‑category hospital vs freestanding coverage status.

    Therapy and Counseling Coverage Rules

    Authorization and coverage rules for therapy, counseling, MNT, and DSMT:

    Therapy evaluation and follow-up PA rules: Office or facility-based PT/OT/ST initial evaluations do not require prior authorization. However, all other billed procedure codes, even if performed on the same date as the initial evaluation, require prior authorization prior to billing. When billing codes other than designated initial evaluation CPT codes, authorization requests must be sent to Evolent (NIA) within 1 business day for outpatient or 2 business days for home health, or to Fidelis within 1 business day for inpatient settings. Non-therapy providers must request prior authorization for services after the initial evaluation directly through Fidelis Care.timing: 1 business day (outpatient)/2 business days (home health)/1 business day (inpatient)

    Prior authorization delegations to Evolent for certain services are noted.

    MNT: Medical Nutrition Therapy is covered for specified diabetes and renal disease ICD‑10 diagnoses; eight visits per year are covered without prior authorization when billed with codes 97802 or 97803 or G0270 and G0271.8 visits/year

    Applicable ICD‑10 qualifying diagnoses are listed in the policy.

    Medical Nutrition Therapy (MNT)

    Covered without prior authorization when ALL of the following are met:

    MNT coverage: Eight Medical Nutrition Therapy visits per year are covered without prior authorization when billed with codes 97802 or 97803 or G0270 and G0271 for qualifying diabetes or renal disease diagnoses as listed in policy.8 visits/year

    See ICD‑10 code list in policy for qualifying diagnoses.

    Diabetes Self-Management Training (DSMT)

    Covered when ALL of the following are met:

    DSMT coverage: Members are allowed 10 hours (20 units) in a continuous 12‑month period for Diabetes Self‑Management Training; services must be provided by certified providers and are covered when billed with codes G0108 and G0109.10 hours/20 units per 12 months

    No prior authorization required.

    Prior Authorization Requirements

    Prior authorization required for certain services:

    Oncology medications PA: Oncology medications and supportive agents require prior authorization via Evolent (formerly New Century Health) for participating providers prior to dispensing or administration; PA requests are submitted via Evolent web portal as specified on the Fidelis website.PA via Evolent

    See Fidelis website/Evolent portal for drug lists and submission details.

    Enteral therapy PA: Enteral therapy HCPCS codes B4034-B4162 (formulas and disposable items) require prior authorization; benefit applies to Part B services.HCPCS B4034-B4162

    Authorization required prior to provision.

    Injectable non-oncology drugs PA: Certain injectable non-oncology drugs listed in the policy require authorization for both participating and non-participating providers; submit PA requests to the Pharmacy Team electronically via e-fax 1-844-235-5090.

    Facilities that are outside New York State, are not licensed/certified/authorized by OASAS/OMH, or are outside Fidelis Care's provider network must continue to request prior authorization for inpatient substance use disorder (SUD) services. Such facilities remain subject to concurrent review throughout the admission. (Providers with questions may contact Fidelis Care behavioral health during business hours.)

    For members with a diagnosis of Low Back Pain, the policy explicitly lists services that are not covered, including prolotherapy and therapeutic injections of steroids into intervertebral discs. Additionally, topical oxygen is not a covered service. These items should not be submitted for coverage when Low Back Pain is the diagnosis.

    The policy clarifies that self‑administered medications are handled under the pharmacy benefit and are not treated as Part B physician‑administered drugs. Providers should route these medications and any associated prior authorization or formulary requirements through the pharmacy/drug benefit processes described on the Fidelis website and related pharmacy resources.

    Within the extract provided, there are no broad, programmatic coverage exclusions beyond the specific code-to-drug mappings and product cross‑references shown. The content in this segment is limited to HCPCS/J‑code mappings and related references rather than narrative exclusion language.

    Out‑of‑network services may be covered when an authorization is obtained for certain Medicare Advantage products; however, members may incur additional co‑pays and deductibles even when such services are authorized. The policy cites the Medicare Advantage Flex Plan (003) and Medicare Advantage without RX (001) as examples where authorized out‑of‑network coverage is available but cost sharing can differ.

    The policy states that CPT code 96110 (noted in the developmental testing section) is a non‑covered service. Providers should not submit claims for 96110 as a covered developmental testing service under this policy.

    Topical oxygen is explicitly listed as not covered. In addition, for Low Back Pain the policy names specific non‑covered services — prolotherapy and therapeutic steroid injections into intervertebral discs — reinforcing that these interventions are excluded from coverage in that clinical context.

    In the portions of the document that contain code‑to‑drug cross‑references and HCPCS/J‑code mappings, the extract does not include explicit statements using the phrase 'not medically necessary.' That segment focuses on billing code mappings and product identifiers rather than clinical necessity determinations.

    Code Lists and Billing Identifiers

    Transplant codes (examples)CPTCovered
    32850listed solid organ transplant codes (examples)
    38204-38242bone marrow / tissue transplant related codes (examples)
    Outpatient surgery and behavioral health codes requiring authorization (documented list)mixedCovered
    43770-43774, 43888Bariatric surgery
    15820-15823Blepharoplasty
    11920-11971, 19300, 19316-19342, 19355, 19370-19396Breast reconstruction
    15011, 15012Skin surgery
    10040, 11300-11313, 11400-11471, 11721Ambulatory surgery codes requiring auth if POS 24
    11200, 11201, 11719, 15769-15829, 17340-17999Codes that require authorization in any place of service
    10060, 11100, 11900, 17000, 20600, 20605Codes requiring preauthorization in freestanding ASCs (bill type 0831)
    65760-65775, 66683, 66987-66991, 67900-67911, 68841Eyelid & ocular surgery
    15830, 15832-15839, 15847, 15876-15879Abdominoplasty, lipectomy, panniculectomy
    19300, 19318Reduction mammoplasty
    1–10 of 24
    1/3
    Outpatient diagnostic/procedure CPT codes requiring authorizationCPTCovered
    43235esophagoscopy procedure (listed as requiring authorization in POS 19/22 when office/ASC available)
    43239esophagoscopy procedure (authorization rule as above)
    43248esophagogastroduodenoscopy procedure (authorization rule as above)
    45378colonoscopy (authorization rule as above)
    45380colonoscopy with biopsy (authorization rule as above)
    45384colonoscopy with removal (authorization rule as above)
    45385colonoscopy with other procedures (authorization rule as above)
    46255sigmoidoscopy related code (authorization rule as above)
    46260sigmoidoscopy related code (authorization rule as above)
    46270sigmoidoscopy related code (authorization rule as above)
    1–10 of 12
    1/2
    DME codes not requiring prior authorization (partial list; new codes effective 4/1/24)HCPCS
    A4239DME code listed as not requiring authorization
    A4287DME code listed as not requiring authorization
    A4341DME code listed as not requiring authorization
    A4342DME code listed as not requiring authorization
    A4457DME code listed as not requiring authorization
    A4564DME code added effective 4/1/24 does not require PA
    A4593DME code added effective 4/1/24 does not require PA
    A4594DME code added effective 4/1/24 does not require PA
    E0152DME code added effective 4/1/24 does not require PA
    E0736DME code added effective 4/1/24 does not require PA
    Imaging and monitoring CPT codesCPT
    95249Ambulatory continuous glucose monitoring (authorization listed)
    77089TBS scan
    77090TBS scan
    77091TBS scan
    77092TBS scan
    Diagnosis codes referenced for counseling/MNT and OB ultrasound rules (examples)ICD-10
    E08.00Example diabetes diagnosis listed for Medical Nutrition Therapy (MNT) coverage
    E10.10Example diabetes diagnosis listed for MNT coverage
    N18.1Chronic kidney disease diagnosis listed for MNT coverage
    Z32.01OB pregnancy diagnosis referenced for OB ultrasound authorization rules
    DSMT billing codesHCPCSCovered
    G0108Diabetes self‑management training (DSMT) group — code allowed without authorization
    G0109DSMT individual — allowed without authorization
    MNT covered codes without PACPTCovered
    97802Medical Nutrition Therapy - initial assessment and intervention, individual, face-to-face
    97803Medical Nutrition Therapy - re-assessment and intervention, individual, face-to-face
    G0270Medical Nutrition Therapy; group (2 or more individuals), per session
    G0271Medical Nutrition Therapy; group (2 or more individuals), each additional 15 minutes
    DSMT covered codesCPTCovered
    G0108Diabetes outpatient self-management training services, individual, per 30 minutes
    G0109Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes
    Enteral Therapy (requires PA)HCPCS
    B4034-B4162Enteral formulas and disposable items (HCPCS range) that require authorization under Part B
    Injectable/biologic/drug HCPCS codes referencedmixed
    multiple J/C/G codes listedNumerous injectable and infusion HCPCS/Codes (e.g., C9047, J0275, J0596, C9145 series, J0129 series, J0223, J1300, J1322, J1305, J1411, J1434, J1440, J1551, etc.) identified as requiring authorization or noted in the Part D/Part B drug lists
    Referenced HCPCS mappings (partial)HCPCS
    J7175recombinant factor viii/von willebrand (mapped in text)
    J7352listed as equivalent mapping for certain products
    Referenced HCPCS mappings (partial)HCPCS
    J7180factor XIII human (Corifact) and related mappings
    J7181factor XIII A‑subunit (Tretten), factor VIII recombinant; other mappings
    J7183vWF human (Wilate), factor VIII recombinant
    J7185factor VIII recombinant (Xyntha) and other mappings
    Referenced HCPCS mappings (partial)HCPCS
    J7186VIII/VWF complex human (Alphanate) and related mappings
    J7188vWF complex (Humate‑P), factor VIII recombinant (Obizur)
    J7189factor VIII recombinant (Obizur) and related mappings
    J7190Novoseven and factor VIII antihemophilic human (Hemofil M)
    Referenced HCPCS mappings (partial)HCPCS
    J7191KoateDVI, Monoclate‑P; factor VIII antihemophilic factor [porcine]
    J7192factor [porcine], factor VIII recom NOS, factor IX non‑recomb
    J7193factor VIII recom NOS, factor IX non‑recomb (AlphaNine/Mononine)
    J7194factor IX complex (Bebulin, Profilnine)
    HCPCS J7xxx group (partial)HCPCS
    J7183Listed with Profilnine or inhalation compound references
    J7185Listed in compound/inhalation sequence
    J7186Appears in compound/inhalation sequence
    J7187Appears paired with J7306/J7307 and V25.1 dates
    J7188Appears in compound code listing
    J7189Appears in compound code listing
    J7190Appears with Profilnine, J7307, and other pairings
    J7191Appears in sequence with J7190-J7194
    J7192Multiple references tied to bitolterol and other inhalation solutions
    J7193Multiple references tied to bitolterol and other inhalation solutions
    1–10 of 11
    1/2
    Compounded/inhalation and selected J-codesHCPCS
    J7634budesonide comp con inh sol
    J7635atropine comp conc inh sol
    J7636atropine comp inh sol
    J7637dexamethasone comp con inh
    J7638dexamethasone comp inh sol
    J7639dornase alfa (Pulmozyme)
    J7641flunisolide comp inh sol
    J7642glycopyrrolate comp con inh
    J7643glycopyrrolate comp inh sol
    J7680terbutaline comp conc inh sol
    1–10 of 13
    1/2
    Oral/other J-codesHCPCS
    J8499rx drug, oral, nonchemo, NOS
    J8515cabergoline, oral
    J8522capecitabine 50 mg
    J8541listed with J9172 mapping
    J8611methotrexate (Jylamvo)
    J8612methotrexate (Xatmep)
    J8650nabilone oral (Cesamet)
    J8999rx drug, oral, chemo, NOS
    Oncology/biologic J-codes (partial)HCPCS
    J9021asparaginase, recombinant (Rylaze)
    J9022atezolizumab (Tecentriq)
    J9035bevacizumab (Avastin)**
    J9041listed with J9248 mapping
    J9042listed with J9249 mapping
    J9043cabazitaxel (Jevtana)
    J9048bortezomib (fresnius kabi)
    J9049bortezomib (Velcade)
    J9051bortezomib (maia)
    J9052carmustine (Accord)
    1–10 of 16
    1/2
    Referenced HCPCS/J/Q/S codes in this sectionmixed
    J9292Listed in mapping to multiple drugs in document
    J9359Referenced in chunk 90
    J9321Referenced in chunk 90
    J9323Referenced in chunk 90
    J9281Referenced in chunk 90
    J9286Referenced in chunk 91
    J9196Referenced in chunk 91
    J9203Referenced in chunk 91
    J9204Referenced in chunk 91
    J9176Referenced in chunk 91
    1–10 of 69
    1/7
    inv-36: OASAS concurrent review waiver period
    Waiver periodFirst 28 days of inpatient SUD admission are not subject to prior authorization or concurrent utilization review if the facility notifies Fidelis Care of the admission and initial treatment plan within two business days using OASAS Appendix A and the LOCADTR Medical Necessity Tool.
    Notification methodFacility may fax or email the OASAS Appendix A Notification Form and LOCADTR to new fax # 833-663-1608 or LOCADTR@fideliscare.org.

    Provider Responsibilities and Submission Requirements

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for the outpatient, diagnostic, therapeutic and drug-related services listed in this section. Failure to obtain prior authorization when required may result in claim denial or financial liability to the provider or member.

    • Outpatient surgery, specified behavioral health testing and services, diagnostic testing, imaging, outpatient therapy after the initial evaluation, therapeutic services, enteral therapy HCPCS B4034–B4162, and many injectable/Part B drugs (HCPCS J‑codes) listed below require prior authorization.
    • Authorization delegated to Evolent (NIA) for many radiology and radiation therapy services; oncology medications/supportive agents require PA via Evolent (my.newcenturyhealth.com) for participating providers.
    Prior Authorization

    DSMT and Enteral Therapy

    Diabetes Self-Management Training (DSMT) and enteral therapy have specific PA rules: DSMT does not require prior authorization when billed with G0108/G0109; enteral therapy (Part B) codes B4034–B4162 require prior authorization.

    • DSMT: Members are allowed 10 hours/20 units in a continuous 12‑month period. No authorization required when billed with G0108 and G0109.

    Definitions and Term Clarifications

    inv-69: Level of Care Determination and tools used for SUD inpatient medical necessity review (LOCADTR)
    DefinitionLOCADTR — Level of Care Determination and Tools used for SUD inpatient medical necessity review; required tool for OASAS inpatient SUD notification and review.
    Role in waiverUse of LOCADTR with OASAS Appendix A Notification qualifies OASAS-licensed facilities for the 28-day no-authorization concurrent review waiver when submitted within two business days.
    Clinical useLOCADTR is used for daily clinical review, periodic consultation with Fidelis Care (starting on or just prior to day 14), discharge planning, and retrospective or continued utilization review after day 28.
    inv-70: OMH Two-Day Notification and Initial Treatment Plan form
    Form nameOMH Two-Day Notification and Initial Treatment Plan form.
    Purpose

    Level-of-Care Specific Criteria

    Modality-Specific Coverage Rules

    TMS

    TMS eligibility: Members over age 18 with confirmed major depressive disorder who have failed multiple trials of medication and evidence-based psychotherapy during the current episode may be eligible for TMS; TMS must be administered using an FDA-cleared device in accordance with labeled indications. Authorization is required for CPT codes 90867, 90868, and 90869.Age >18; prior treatment failures

    Authorization request routes: email qhcmbh@fideliscare.org, fax 833-561-0098, or phone 1-888-FIDELIS (follow Behavioral Health prompts).

    ECT

    Outpatient ECT: Outpatient electroconvulsive therapy (ECT) is a listed behavioral health service that requires authorization (CPT 90870).N/A

    Authorization required prior to service.

    Visit and Unit Limits

    inv-82: Partial hospitalization, Intensive outpatient (limit metadata)
    Partial hospitalization (PH)PH (Revenue codes 912, 913, 944, 945; HCPCS H0035) is listed under outpatient behavioral health services that may require authorization per policy.
    Intensive outpatient treatment (IOP)IOP (Bill type 131, Revenue code 905 or 912, CPT 90899, S9480, HCPCS H2013) is listed as a specified service subject to authorization.
    Authorization stanceAuthorization requirement for outpatient behavioral health was removed for most services, but specified categories such as PH and IOP continue to require authorization as listed.
    inv-83: Medical Nutrition Therapy (MNT) without authorization — 8 visits
    No-PA visitsEight Medical Nutrition Therapy visits per year are covered without prior authorization when billed with codes 97802, 97803, G0270 or G0271.
    Qualifying diagnoses

    Policy Background

    This policy establishes the authorization and utilization review framework for inpatient admissions (medical, behavioral health, and substance use disorder), and for specific outpatient surgeries and behavioral health services. It defines exceptions for in‑state OMH‑licensed pediatric inpatient admissions (a 14‑day notification‑based no‑authorization period when the facility notifies Fidelis within two business days) and OASAS‑licensed SUD inpatient admissions (a 28‑day notification‑based no‑authorization period when the facility notifies Fidelis within two business days and uses LOCADTR), and it requires authorization for all other inpatient facility services and listed outpatient procedures. Providers are instructed to follow the notification, prior authorization, and delegated PA submission processes described in the policy.

    Policy Summary
    PayerFidelis Care
    PolicyPrior Authorization and Coverage Criteria — Inpatient, Outpatient and Behavioral Health Services
    Policy CodePolicy N/A
    Change TypeBehavioral health carve‑in added
    Effective DateN/A
    Next Review DateN/A
    Key ActionObtain prior authorization for all inpatient facility admissions and for listed outpatient surgical, procedural and selected behavioral health services; notify Fidelis Care within two business days for OMH/OASAS in-state inpatient admissions to qualify for initial no-authorization periods.
    SourceLink
    On This Page
    Coverage and Authorization CriteriaCode Lists and Billing IdentifiersProvider Responsibilities and Submission RequirementsDefinitions and Term ClarificationsLevel-of-Care Specific CriteriaModality-Specific Coverage RulesVisit and Unit LimitsPolicy Background
    N/A

    Authorization required prior to service.

    Partial hospitalization and intensive outpatient: Partial hospitalization (Revenue codes 912, 913, 944, 945; HCPCS H0035) and Intensive Outpatient Treatment (bill type 131; revenue 905 or 912; CPT 90899; S9480; HCPCS H2013) require authorization.N/A

    Follow facility/billing instructions for authorization.

    TMS criteria summary: Transcranial Magnetic Stimulation (TMS) is covered with authorization for CPT codes 90867, 90868, 90869. Members over 18 may be eligible when TMS is administered using an FDA-cleared device per labeled indications, with a confirmed diagnosis of major depressive disorder and failure to respond to multiple trials of medication and evidence-based psychotherapy during the current episode.Age >18 and prior treatment failures

    Authorization requests may be submitted via email, fax, or phone following Behavioral Health prompts.

    DSMT: Diabetes Self‑Management Training is allowed 10 hours (20 units) in a continuous 12‑month period, must be provided by certified providers, are billed with G0108/G0109, and do not require prior authorization.10 hours/20 units per 12 months

    No prior authorization required.

    PA required

    Specific J/C codes are listed in the policy extracts (see code lists).

    Facility responsibilities during waiver
    Perform daily clinical review; consult with Fidelis Care starting on or just prior to day 14 to ensure LOCADTR use; provide written discharge plan determined using LOCADTR prior to discharge.
    Post-waiver reviewServices may be subject to utilization review after day 28 or reviewed retrospectively to assess medical necessity.
    inv-37: OMH concurrent review waiver period (pediatric)
    Waiver period (pediatric OMH)First 14 days of inpatient mental health admission for members under age 18 are not subject to prior authorization or concurrent utilization review when facility notifies Fidelis Care within two business days using the OMH Two-Day Notification and Initial Treatment Plan form.
    Notification submissionSubmit OMH Two-Day Notification and Initial Treatment Plan to Fidelis Care by fax (833-561-0094) or email to Mental_Health_Admission@fideliscare.org within two business days of admission.
    Facility requirements during waiverPerform daily clinical review and participate in periodic consultation with Fidelis Care to ensure use of OMH-approved evidence-based clinical review criteria appropriate to patient age.
    AdultsInpatient mental health services for members age 18 and older require prior authorization and are subject to concurrent review throughout admission.
    inv-38: OB ultrasound limit without authorization
    Authorized OB ultrasound without PAThe first 4 OB ultrasounds can be performed without prior authorization.
    Normal pregnancy thresholdFive or more ultrasounds for a normal pregnancy (diagnosis codes Z32.01, Z33.1, Z34.00-Z34.03, Z34.80-Z34.83, Z34.9-Z34.93) require authorization.
    High-risk pregnanciesOB ultrasounds for listed high-risk pregnancy diagnosis codes (O09.x series and specified O36 codes) do not require authorization.
    inv-39: DSMT limit
    DSMT allowanceMembers are allowed 10 hours (20 units) in a continuous 12-month period for Diabetes Self-Management Training.
    Provider requirementServices must be provided by certified providers.
    Billing codesBill DSMT services with codes G0108 (individual) and G0109 (group).
    inv-40: Quantity/month or unit — no explicit numeric thresholds in these chunks
    Numeric thresholds present?No explicit numeric quantity-per-month or per-unit thresholds are provided in these code-to-drug mapping chunks.
    Implication for claimsProviders should reference specific policy sections for service-specific limits (e.g., MNT, DSMT) rather than relying on numeric thresholds in these mapping chunks.
    Coding cross-referenceThese chunks focus on HCPCS/J-code to product mappings and do not define monthly or per-unit limits.
  1. Enteral Therapy: HCPCS codes B4034–B4162 describe enteral formulas/disposables that require authorization under the Part B benefit.
  2. Documentation Required

    HCPCS J‑codes Referenced for Prior Authorization

    Many HCPCS J‑codes and related Q/QS codes are referenced in the drug listing and require prior authorization. Providers must include the specific HCPCS/J‑code and the drug/product name on authorization requests to support review.

    • Large list of J‑codes (e.g., J7175, J7180–J7194, J7634–J7641, J9026–J9376, J9361, J9380–J9395, J9999 and others) appear in the source listing and are treated as PA‑sensitive.
    • Document the HCPCS J‑code AND the specific drug name/product to avoid mapping errors and potential denials.
    Prior Authorization

    Verify PA Requirements for Listed J‑codes

    Verify whether a listed J‑code requires prior authorization before billing; some codes are subject to Evolent (NCH) review and some to Fidelis Pharmacy Team review (e‑fax).

    • Oncology medications/supportive agents: PA required via Evolent (my.newcenturyhealth.com) for participating providers.
    • Non‑oncology injectable drugs: submit PA requests to Fidelis Pharmacy Team via e‑fax to 1‑844‑235‑5090 (new as of 10/1/2023).
    • Non‑participating providers may have different submission routes for oncology requests (see plan guidance).
    Denial Risk

    Potential Denial for Incorrect Coding

    Claims may be denied if coding is incorrect, inconsistent with the documented drug product, or if an incorrect J‑code is submitted for the drug administered. Ensure mappings between drug name and J‑code are accurate on PA requests and claims.

    • Include both HCPCS/J‑code and drug/product name on the authorization request to reduce risk of denial for incorrect coding or inconsistent mappings.
    Note

    No Explicit Authorization or Denial Rule

    Some segments of the drug/code mapping listing do not state an explicit authorization or denial rule within the text. When an explicit PA requirement is not present for a specific code in this section, verify coverage rules with Evolent or Fidelis prior to service.

    • The large HCPCS/J‑code list includes entries where no explicit PA/denial rule is stated in the excerpted text — confirm operational PA rules in the plan formulary or via the Evolent/Fidelis portals.
    Prior Authorization

    Admission Notification Requirements

    Admission notification and limited prior‑authorization waivers apply for certain licensed facilities. OMH‑licensed inpatient pediatric facilities and OASAS‑licensed inpatient SUD facilities have notification requirements in lieu of immediate PA for initial days of admission — providers must notify Fidelis within the stated timelines.

    • OMH licensed inpatient mental health (members <18): notify Fidelis of admission and initial treatment plan within two business days using the OMH Two‑Day Notification form; fax to 833‑561‑0094 or email Mental_Health_Admission@fideliscare.org.
    • OASAS licensed Inpatient SUD facilities: notify Fidelis within two business days using the OASAS Appendix A Notification Form and LOCADTR tool; fax to 833‑663‑1608 or LOCADTR@fideliscare.org.
    • All inpatient admissions require authorization except emergency stabilization; inpatient reviews occur for medical necessity.
    Prior Authorization

    Timing for Authorization Requests when Initial Evaluation Rendered

    Timing rules: initial evaluations for therapy and some outpatient services have special authorization timing. If services other than the designated initial evaluation CPT codes are billed on the same date, an authorization must be submitted within the plan’s specified business‑day window.

    • Office/facility PT/OT/ST initial evaluations do not require PA; however, all other billed procedure codes—even on the same date—require authorization prior to billing.
    • When initial evaluation rendered in outpatient setting, send authorization to Evolent within 1 business day (outpatient) or 2 business days (home health); inpatient settings to Fidelis within 1 business day.
    • For therapy services in inpatient settings (POS 31 & 32), send PA requests to fax 833‑663‑1611.
    Prior Authorization

    Oncology PA Process

    Oncology prior authorization process: participating providers must request PA through Evolent (formerly New Century Health). Non‑participating providers and certain oncology requests may route to Fidelis or Wellcare by Fidelis Care per plan directions.

    • Participating providers: request oncology medication/supportive agent PA at my.newcenturyhealth.com or via the 'Evolent Oncology Program' link on Fidelis provider resources.
    • Non‑participating providers: oncology requests may require review by the Wellcare By Fidelis Care plan via e‑fax to 1‑844‑235‑5090; follow plan instructions for non‑participating workflows.
    Documentation Required

    Coding Documentation Required for PA

    Coding documentation: authorization requests must include the specific HCPCS/J‑code and the drug name/product. Use the designated request forms (e.g., Psychological/Neuropsychological testing request form) when required.

    • For psychological/neuropsychological testing (96116–96146) submit the designated testing request form.
    • For J‑code drug requests include HCPCS/J‑code + drug/product name to support correct mapping and reduce denials.
    Note

    No Provider Documentation or Submission Instructions in All Listings

    There are areas in the source listing where provider submission instructions or documentation pathways are not specified. In those cases, providers should confirm the required submission method with Fidelis or Evolent prior to delivery of service.

    • If no provider documentation or submission instruction is present for a given code in this excerpt, verify the correct PA submission route (Fidelis UM portal, Evolent portal, or Pharmacy e‑fax) before billing.
    Documentation Required

    Voicemail HIPAA‑Compliance Requirement

    Voicemail HIPAA‑compliance: UM messages may be left only if the provider’s voicemail is HIPAA compliant. Greetings must identify the mailbox owner and organization and state the mailbox is confidential and that PHI may be left. If voicemail is not HIPAA compliant, only a generic message will be left and a callback requested.

    • If voicemail meets HIPAA requirements, a detailed UM message will be left; otherwise UM will leave a generic message and attempt direct contact again per Department of Health Reasonable Effort Policy.
    Step Therapy

    No Step Therapy Rules Present in This Section

    No step therapy rules are present in this section excerpt; drug/code listings are extensive but do not include detailed step therapy steps here. Providers should consult the Part B Step Therapy Policy link and the plan formulary for complete step therapy requirements.

    • For a list of drugs that require step therapy, see the Part B Step Therapy Policy on the Fidelis website.
    • This section contains drug/code listings but does not detail step therapy algorithms.
    Billing Rule

    Drug/Code Listings (No Step Therapy Detailed Here)

    Drug/code listings are included in the plan materials but many entries in this excerpt are code mappings without embedded step therapy details. Treat the listing as a reference of PA‑sensitive codes and verify clinical rules and step therapy elsewhere.

    • Extensive HCPCS/J‑code and Q/QS listings appear throughout the source (examples: J7175, J7180–J7194, J7634–J7641, J9028, J9361, Q0138, Q0510–Q0521, etc.).
    • Use the Fidelis formulary and Evolent program links for up‑to‑date PA, step therapy, and coverage determinations.
    Used by OMH-licensed inpatient pediatric facilities to notify Fidelis Care of admission and initial treatment plan to qualify for the 14-day no-authorization concurrent review waiver.
    Submission detailsSubmit form to Fidelis Care by fax (833-561-0094) or email Mental_Health_Admission@fideliscare.org within two business days of admission.
    inv-71: OMH-regulated BH service categories
    Service categories listedOMH-regulated behavioral health service categories include Psychiatric Inpatient, Mental Health Outpatient Treatment and Rehabilitative Services, Assertive Community Treatment (ACT), Continuing Day Treatment (CDT), Comprehensive Psychiatric Emergency Program (CPEP), Partial Hospitalization (PH), PROS, and Crisis Residence.
    Coverage changeCrosswalk indicates MAP Medicaid coverage for many OMH/OASAS service categories beginning January 1, 2023, with hospital and freestanding settings specified in the crosswalk.
    Reference noteSee crosswalk entries for per-category hospital vs freestanding coverage status and specific OMH regulation parts cited.
    inv-72: MNT definition
    TermMedical Nutrition Therapy (MNT)
    Context in policyMNT is described in counseling services section with qualifying ICD-10 diagnoses (diabetes and renal disease) and visit limits specified elsewhere in policy.
    Related codesMNT visit codes include 97802, 97803, G0270 and G0271 (used for coverage without prior authorization when criteria met).
    inv-73: DSMT definition
    TermDiabetes Self-Management Training (DSMT)
    DefinitionStructured diabetes education provided by certified providers; billed with G0108 (individual) and G0109 (group).
    Limit notedPolicy specifies allowance of 10 hours / 20 units in a continuous 12-month period.
    inv-74: HCPCS J‑code mapping definition (cross-reference)
    DefinitionHCPCS J-code cross-reference — mapping between HCPCS J-codes and specific biologic/infusible drug products as listed in the policy's prescription drug information section.
    PurposeUsed to identify the exact J-code and corresponding drug/product when submitting Part B drug claims and prior authorization requests to avoid coding mismatches and denials.
    Provider actionDocument the specific HCPCS J-code and corresponding product name as shown in the listings to support PA requests and claims.
    inv-75: HCPCS J-code explanation
    What it isHCPCS J-code — alphanumeric billing code used for physician‑administered (injectable/infused) medications.
    Use in policyNumerous J-codes are listed with drug mappings; providers should verify PA requirements for specific J-codes when billing infused or injected drugs.
    Risk of miscodingClaims using incorrect J-code mappings or unsupported HCPCS codes may be denied if billed inconsistently with the provided cross-references.

    PH, CPEP, ACT, CDT, PROS, Crisis Residence, Psychiatric Inpatient

    OMH-regulated service coverage under carve-in: Partial Hospitalization (PH), Comprehensive Psychiatric Emergency Program (CPEP), Assertive Community Treatment (ACT), Continuing Day Treatment (CDT), Personal Recovery Oriented Services (PROS), Crisis Residence, and Psychiatric Inpatient services are defined in the OMH/OASAS crosswalk; MAP Medicaid coverage for these categories is indicated to begin January 1, 2023 with hospital and freestanding settings specified per category.

    Refer to the carve-in crosswalk for per-category details and setting-specific coverage.

    MNT coverage applies for specified diabetes and renal disease ICD-10 codes listed in the policy.
    Billing codesUse CPT codes 97802 and 97803 or HCPCS codes G0270 and G0271 for MNT claims.
    inv-84: Diabetes Self‑Management Training (DSMT) — 10 hours / 20 units
    Allowed amountDiabetes Self-Management Training (DSMT) — 10 hours (20 units) in a continuous 12-month period.
    Provider requirementServices must be provided by certified providers and no longer require prior authorization.
    Billing codesBill DSMT with G0108 (individual, per 30 minutes) and G0109 (group, per 30 minutes).
    inv-85: Medical Nutrition Therapy visits without authorization — 8
    MNT visits without PA (repeat)Eight MNT visits per year covered without prior authorization when billed with 97802/97803 or G0270/G0271.
    Relevant ICD-10sCoverage tied to qualifying diabetes and renal disease ICD-10 codes listed in policy.
    Claims adviceEnsure correct MNT CPT/HCPCS codes are used to avoid PA or denial issues.
    inv-86: Diabetes Self-Management Training — 10 hours (20 units)
    DSMT limit (repeat)10 hours (20 units) in a continuous 12-month period; services provided by certified providers and billed with G0108/G0109.
    Authorization statusDSMT no longer requires prior authorization per policy.
    DocumentationBill with correct G0108/G0109 codes to reflect DSMT service delivery and units/hours used.